Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
Rocky Strollo, Ernesto Maddaloni, Marco Dauriz, Claudio Pedone, Raffaella Buzzetti, Paolo Pozzilli
Topics & Concepts
MedicineDipeptidyl peptidase-4Coronavirus disease 2019 (COVID-19)Diabetes mellitus2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineType 2 diabetesVirologyEndocrinologyDiseaseInfectious disease (medical specialty)OutbreakPeptidase Inhibition and AnalysisDiabetes Treatment and ManagementPancreatitis Pathology and Treatment